Mag­netic sieve tech­nol­ogy joins the fight against leukaemia

Computer Shopper - - NEED TO KNOW -

BLOOD DISEASES ARE get­ting the full at­ten­tion of MediSieve, a com­pany that has cre­ated a mag­netic sieve al­ready see­ing some suc­cess in the fight against malaria. MediSieve’s new tech­nol­ogy can use mag­netic par­ti­cles to tar­get prob­lem zones in the blood and could help bet­ter treat can­cer.

Founder and CEO of MediSieve, Dr Ge­orge Frod­sham, said: “We have al­ways been de­vel­op­ing a plat­form tech­nol­ogy to tar­get a wide range of blood-borne diseases. We re­cently an­nounced our plans to tar­get sep­sis and now I’m very ex­cited to share our work against leukaemia, too.”

The mag­netic fil­ter, or sieve, that proved so suc­cess­ful at deal­ing with malaria will soon be tested in med­i­cal tri­als, while the firm’s tech­ni­cians will turn their at­ten­tions to the treat­ment of other lifethreat­en­ing ill­nesses. MediSieve has brought in an ex­pert on mag­netic par­ti­cles, Dr Cristina Blanco An­du­jar, to help push things for­ward.

Dr Blanco said: “I am in­cred­i­bly pas­sion­ate about what we’re try­ing to do here at MediSieve, and I be­lieve that by col­lab­o­rat­ing with ex­perts in our field we will be able to reach our goals.”

The MediSieve would be used prior to chemo­ther­apy, where it might im­prove the ef­fec­tive­ness of the drug, and re­duce the some­times pun­ish­ing side ef­fects. MediSieve ex­pects to have a prod­uct ready in 2021.

Newspapers in English

Newspapers from UK

© PressReader. All rights reserved.